DIA Biosimilars 2013

i3

Eli Lilly expands its outsourcing partnership with i3 Statprobe

Tuesday, September 28, 2010 07:40 AM

Expanding the outsourcing support of its clinical trials, Eli Lilly is transferring U.S. medical writing and biostatistical services to i3 Statprobe, a move that expands the business relationship formed between the two companies in 2008 when Lilly transferred the majority of its domestic data management activities to i3.

More... »

Cenduit: Now with Patient Reminders

CenterWatch Monthly June 2010

Thursday, June 3, 2010 08:38 AM

i3 Research, PPD, Kendle, Covance Rated Top CROs in Europe in 2010

More... »

CRF Health – eCOA Forum

i3 Takes on PRO Measurement with QualityMetric Deal

Wednesday, April 7, 2010 07:00 AM

Ingenix, the parent company of pharmaceutical services company i3, added patient-reported outcomes (PRO) services to its portfolio with the recent acquisition of QualityMetric for an undisclosed amount.

More... »

Lindevall Returns as CEO of Encorium

Friday, January 15, 2010 06:44 AM

CEO musical chairs continues at Wayne, Pa.-based contract research organization (CRO) Encorium . The company has reappointed Dr. Kai Lindevall as CEO, replacing David Ginsberg who left the company last summer when Encorium sold its U.S. business to Pierrel Research USA and Ginsberg became CEO there. Ginsberg had replaced Lindevall as CEO in September 2008. Lindevall, who replaced Kenneth Borow, M.D., as CEO in February 2008, has served as executive chairman since Ginsberg became CEO. Board member Shahab Fatheazam will serve as Encorium’s new chairman.  

More... »

i3 Acquires Regulatory Services Company CanReg

Monday, January 4, 2010 07:35 AM

Pharmaceutical services company i3 has expanded its regulatory compliance services through the recent acquisition of Canada-based regulatory affairs consulting firm CanReg. Neither company would comment on the financial terms of the deal, which was completed on December 1, 2009.

More... »

i3, Acurian in Patient Recruitment Deal

Tuesday, December 1, 2009 08:01 AM

Pharmaceutical services company i3 has entered into an agreement with Acurian, a provider of patient recruitment and retention solutions, to provide study sponsors with a more robust solution to recruit investigators for clinical trials. 

More... »

i3 Pharma Resourcing Expands in Europe

Friday, November 20, 2009 09:07 AM

i3 Pharma Resourcing launched resourcing services in Switzerland and Belgium.

More... »

i3 Streamlines Clinical Trial Management With New Technology

Wednesday, March 18, 2009 09:18 AM

Contract research organization (CRO) i3 launched a new web-based clinical trial and data management program that will replace the need for multiple systems and applications to manage study activities.

More... »

CenterWatch Monthly October 2008

Friday, October 3, 2008 02:44 PM

Trio of Companies in Strategic Outsourcing Partnerships with Lilly

More... »

WCCT Names Vice President of Clinical Operations

Wednesday, September 24, 2008 04:29 PM

West Coast Clinical Trials (WCCT) appointed J. Jon Rojas vice president, clinical operations, for the Cypress, Calif.-based early stage CRO. Rojas will provide management oversight and strategic direction of the phase I business unit. Prior to joining WCCT, Rojas served as senior vice president of clinical services and support at OmniComm.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs